ReviewApplied biochemistry and biotechnology2026
AlGaN/GaN HEMT Biosensors for Next-Generation Applications: a State-of-the-Art Review.
Review in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dielectric-Modulated Nanogap Engineered AlGaN/GaN MOSHEMT: A High-Performance Platform for Neutral and Charged Biomolecule Detection.Applied biochemistry and biotechnology · 2026Article
- Modeling and Sensitivity Analysis of GaN HEMT Biosensor.Biosensors · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AlGaN/GaN high-electron-mobility transistor (HEMT) biosensors are revolutionizing real-time, label-free, and ultra-sensitive biomolecular detection by addressing major limitations of conventional FET-based biosensors such as oxide instability, chemical degradation, and poor sensitivity in physiological environments. Their superior electron mobility, wide bandgap, and inherent chemical robustness enable stable operation in complex biological media. This review critically examines the structural and electronic advantages of AlGaN/GaN HEMTs and their role in mitigating challenges like Debye screening and functionalization instability. Applications across cancer and cardiovascular diagnostics, infectious disease detection, metabolic disorder monitoring, and molecular sensing are systematically analyzed. Finally, future perspectives highlight the integration of AlGaN/GaN HEMT biosensors with wearable systems, artificial intelligence–assisted analytics, and standardized testing protocols to advance next-generation point-of-care diagnostics and personalized healthcare.
Indexed as
Identifiers
41653261What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.